Related Experiment Video
Updated: Dec 29, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Optimizing Time to Antibiotic Administration in Children with Possible Febrile Neutropenia through Quality
Beech Burns1, Melinda Hartenstein1, Amber Lin1
1Department of Emergency Medicine, Oregon Health and Science University, Portland, Ore.
Insights
Prompt antibiotic administration for febrile neutropenia in children is crucial. A quality improvement initiative successfully reduced time to antibiotic (TTA) delivery to under 60 minutes for over 80% of pediatric oncology patients.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Quality Improvement Science
Background:
- Febrile neutropenia is a serious chemotherapy complication in children.
- Timely antibiotic treatment is vital for reducing morbidity and mortality.
- A <60-minute time to antibiotic (TTA) administration is a key quality metric.
Purpose of the Study:
- To implement a quality improvement initiative to achieve TTA < 60 minutes in >80% of eligible pediatric oncology patients.
- To enhance the promptness of antibiotic delivery in a pediatric emergency department setting.
Main Methods:
- Utilized Plan-Do-Study-Act (PDSA) cycles to streamline antibiotic ordering and preparation.
- Focused on reducing time from patient arrival to antibiotic order.
- Implemented pharmacy expediting and pre-arrival ordering strategies.
- Employed statistical process control for outcome measurement.
Main Results:
- Mean TTA decreased from 64 to 53 minutes post-intervention.
- Percentage of patients receiving antibiotics within <60 minutes increased from 59% to 84%.
- Sustained improvements were observed, with 85% of patients receiving antibiotics within the goal time.
Conclusions:
- A multi-cycle PDSA initiative effectively reduced TTA in pediatric febrile neutropenia patients.
- The initiative significantly increased the proportion of patients receiving timely antibiotic therapy.
- The quality improvement strategy successfully met and sustained the <60-minute TTA benchmark.
Abstract:
Febrile neutropenia is a potentially life-threatening complication of chemotherapy in pediatric oncology patients. Prompt initiation of antibiotic therapy may minimize morbidity and mortality associated with this condition, and time to antibiotic (TTA) administration <60 minutes is used as a quality benchmark by many institutions. We implemented a quality improvement initiative to achieve TTA < 60 minutes in >80% of eligible patients in the pediatric emergency department.
Methods:
After collecting baseline data, we employed consecutive PDSA cycles to (i) reduce time to antibiotic order after patient arrival; (ii) expedite the preparation of antibiotic by pharmacy; and (iii) enable antibiotic ordering before patient arrival. Statistical process control methodologies were used for key outcome measures to compare pre-intervention, post-intervention, and maintenance periods.
Results:
Comparing pre-intervention and post-intervention years, mean TTA decreased from 64 to 53 minutes and the percentage of patients receiving antibiotics in <60 minutes increased from 59% to 84%. Improvements were sustained in the maintenance period of the project, with mean TTA administration of 44 minutes and 85% of patients receiving antibiotics within our stated goal.
Conclusion:
Through a series of PDSA cycles, we decreased TTA and increased the percentage of febrile neutropenia patients receiving antibiotics in <60 minutes.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Urinary Tract Infection IV: Nursing Management
Dosage Interval and Administration Route: Determination Methods